NorthCrest Asset Manangement’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.32M | Sell |
18,996
-91
| -0.5% | -$6.32K | 0.04% | 269 |
|
|
2025
Q1 | $1.4M | Sell |
19,087
-4,210
| -18% | -$309K | 0.04% | 247 |
|
|
2024
Q4 | $1.53M | Sell |
23,297
-442
| -2% | -$29K | 0.05% | 235 |
|
|
2024
Q3 | $1.85M | Sell |
23,739
-35
| -0.1% | -$2.73K | 0.06% | 212 |
|
|
2024
Q2 | $1.85M | Sell |
23,774
-370
| -2% | -$28.9K | 0.06% | 206 |
|
|
2024
Q1 | $1.64M | Sell |
24,144
-780
| -3% | -$52.8K | 0.06% | 219 |
|
|
2023
Q4 | $1.68M | Sell |
24,924
-525
| -2% | -$35.4K | 0.06% | 210 |
|
|
2023
Q3 | $1.72M | Sell |
25,449
-341
| -1% | -$23.1K | 0.07% | 200 |
|
|
2023
Q2 | $1.85M | Sell |
25,790
-505
| -2% | -$36.1K | 0.07% | 193 |
|
|
2023
Q1 | $1.83M | Buy |
26,295
+1,432
| +6% | +$99.4K | 0.08% | 186 |
|
|
2022
Q4 | $1.69M | Sell |
24,863
-1,765
| -7% | -$120K | 0.1% | 132 |
|
|
2022
Q3 | $1.46M | Buy |
26,628
+784
| +3% | +$43K | 0.08% | 169 |
|
|
2022
Q2 | $1.71M | Sell |
25,844
-159
| -0.6% | -$10.5K | 0.09% | 164 |
|
|
2022
Q1 | $1.73M | Buy |
26,003
+1,279
| +5% | +$84.8K | 0.08% | 143 |
|
|
2021
Q4 | $1.44M | Buy |
+24,724
| New | +$1.44M | 0.08% | 186 |
|